The management of mild asthma

Paul M. O'Byrne, Helen K. Reddel, Richard Beasley

Source: Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020
Journal Issue: April
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Paul M. O'Byrne, Helen K. Reddel, Richard Beasley. The management of mild asthma. Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Refining asthma treatment for mild asthma
Source: Virtual Congress 2020 – Rethinking asthma
Year: 2020


Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011


Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008



The use of omalizumab in the management of severe chronic paediatric asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Evolution from mild to severe asthma; the severe asthma clinic perspective
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019


Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017

Difficult to treat asthma
Source: Annual Congress 2006 - Clinical year in review
Year: 2006


Assessing severe asthma
Source: Eur Respir J 2016; 48: 611-613
Year: 2016


The ERS/EAACI statement on severe exacerbations of asthma, and how to deal with non-allergic severe asthma
Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma
Year: 2019


Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021



Predictors of severe exacerbations in patients with moderate and severe asthma
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018



Only severe asthma?
Source: International Congress 2019 – PG11 Severe paediatric asthma
Year: 2019


Short-term effects of pulmonary rehabilitation on asthma control in patients with moderate-severe unstable asthma
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019

Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Immunotherapy in severe asthma
Source: ERS webinar 2021: Immunotherapy in severe asthma
Year: 2021


Management of severe and difficult-to-treat asthma
Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping
Year: 2013


Evaluation and management of difficult-to-control asthma
Source: Annual Congress 2004 - PG12 - Asthma: from bench to bedside
Year: 2004